packageIdelalisib

idelalisib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Idelalisib is an anticancer medicine used to treat certain B-cell blood cancers, including chronic lymphocytic leukemia and several types of lymphoma. It is authorised in the European Union for non-Hodgkin lymphoma and chronic lymphocytic leukemia, and carries a boxed warning.

Summary written by glm-5.3-flash from Wikidata Q5908266 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:idelalisib
ATC codes:L01EM01, L01XX47
DrugBank:DB09054
PubChem CID:11625818
ChEBI:82701
Wikidata:Q5908266
formula:C22H18FN7O
molar mass:415.432 g/mol (PubChem CID 11625818)
logP:3.7 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown